Skip to content

Clinical Study on Disposable Sterile Urinary Catheter

A Multicenter, Prospective, Randomized Controlled Clinical Study to Evaluate the Safety and Effectiveness of Disposable Sterile Urinary Catheter

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05651217
Enrollment
136
Registered
2022-12-14
Start date
2019-12-11
Completion date
2023-02-10
Last updated
2023-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Catheters, Urinary Tract Infection

Brief summary

This study is a multicenter, randomized controlled study, with the urinary tract infection rate at the time of catheter insertion for 1 week as the primary end point. By comparing the clinical safety and effectiveness of two kinds of urethral catheters, to evaluate the clinical application effect of one kind of urethral catheters.

Interventions

DEVICEdisposable urinary catheter

The trial group was intervened with disposable sterile urinary catheter. The model of the trial group includes two chamber type (Fr8, Fr10, Fr12, Fr14, Fr16, Fr18, Fr20, Fr22, Fr24) and three chamber type (Fr16, Fr18, Fr20, Fr22, Fr24).

DEVICEsuper smooth antibacterial urinary catheter

the control group was intervened with ultra smooth antibacterial catheter. The control group models include single chamber (6Fr, 8Fr, 10Fr, 12Fr, 14Fr, 16Fr, 18Fr, 20Fr, 22Fr, 24Fr), double chamber (6Fr, 8Fr, 10Fr, 12Fr, 14Fr, 16Fr, 18Fr, 20Fr, 22Fr, 24Fr, 26Fr, 28Fr, 30Fr), and three chamber (16Fr, 18Fr, 20Fr, 22Fr, 24Fr, 26Fr)

Sponsors

Shandong Branden Med.Device Co.,Ltd
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 18-80 year old patients; * Retained catheter ≥ 7 days; * Patients who were conscious and had good communication skills and volunteered to participate in the study.

Exclusion criteria

* Pregnant and lactating female patients; * Diabetes patients; * Patients allergic to sulfadiazine, silica gel and stainless steel; * Urethral malformation, acute urethral injury, prostate disease, intermittent catheterization, suprapubic cystostomy and other patients who are not suitable for catheterization; * Patients who have used urinary catheters for a long time or had catheters retained within one week; * Patients who are participating in other clinical trials that interfere with this trial.

Design outcomes

Primary

MeasureTime frameDescription
Urinary tract infection rateone weekIn accordance with the Diagnostic Criteria for Catheter associated Urinary Tract Infection in the Technical Guidelines for the Prevention and Control of Catheter associated Urinary Tract Infection (Trial) formulated and issued by the Ministry of Health in 2011. Although the patient has no symptoms, he or she has endoscopic examination or catheterization within one week. If the number of Gram positive cocci colonies in urine culture ≥ 10 has 4 cfu/ml, and the number of Gram negative bacilli colonies ≥ 10 has 5 cfu/ml, he or she should be diagnosed as asymptomatic bacteriuria. If the patient has urinary tract irritation symptoms such as frequent urination, urgent urination, and painful urination, or has lower abdominal tenderness, renal area percussion pain, with or without fever (\>38.0 ℃), it is symptomatic bacteriuria.

Secondary

MeasureTime frameDescription
level of urethral irritation10 minutes after catheterizationLevel 0, no discomfort at all; Grade I, slight discomfort, but tolerable; Grade II, moderate discomfort, intolerable, urgency of urination, urethral pain, abdominal distension; Grade III, severe discomfort, extremely intolerable, obvious distension of lower abdomen, urethral pain, urgency of urination, and the desire to pull out the catheter, accompanied by restlessness, increased heart rate, and elevated blood pressure.
Incidence of device related adverse events72 hoursThe safety of clinical use of the device was evaluated based on the incidence of adverse events related to the device that occurred after the subject placed the tube. Including: balloon leakage, rupture, catheter self falling off, difficulty in pulling out catheter, catheter blockage, urine retention, urine leakage, hematuria, urethral injury, etc; It can be judged according to clinical experience, and imaging methods can be used when necessary.
time of catheter durationone weekTime from insertion to removal of catheter
Success rate of catheterization10 minutes after catheterizationThe success of catheterization is based on the evaluation of each instrument, which can be placed at the catheterization site as expected and catheterization can be carried out smoothly.
rate of packaging integrity10 minutes after catheterization
rate of device defect rate10 minutes after catheterizationThe package is damaged, the balloon cannot be inflated, and the balloon leaks or breaks
rating of operation convenience10 minutes after catheterizationIncluding excellent: very convenient, good: relatively convenient, poor: poor convenience

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026